DNLI
Denali Therapeutics Inc.$20.42-0.80 (-3.77%)Prev Close$21.22·MCap$3.54B·P/E—·Vol1.25M·Yield—
▲
Buys (12M)
0
$0.00
▼
Sells (12M)
6
$1.30M
◆
Net Activity
Net Seller
$1.30M
●
Active Insiders
4
last 12 mo
Over the past 12 months, insider activity at Denali Therapeutics Inc. (DNLI) has been exclusively selling, with 0 insider purchases totaling $0.00 and 6 insider sales totaling $1.30M. The most recent insider transaction was by Chin Peter Scott (officer: Chief Medical Officer), who sold $36.9K worth of shares on Sep 9, 2026. Denali Therapeutics Inc. operates in the Healthcare sector, within the Biotechnology industry, with a market cap of $3.54B.
DNLI Insider Trading Activity
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| Sep 9, 2026 | Chin Peter Scott | officer: Chief Medical Officer | Sell | 1,654 | $22.29 | $36.9K | 204,538 |
| Sep 4, 2026 | Thornberry Nancy | director | Sell | 11,439 | $22.90 | $261.9K | 20,301-36% |
| Sep 3, 2026 | Schuth Alexander O. | officer: COFO and Secretary | Sell | 2,768 | $23.44 | $64.9K | 278,995 |
| Aug 13, 2026 | Schuth Alexander O. | officer: COFO and Secretary | Sell | 2,857 | $25.07 | $71.6K | 281,763 |
| Jan 6, 2026 | Schuth Alexander O. | COFO and Secretary | Sell | 17,218 | $16.50 | $284.1K | 0 |
| Jan 6, 2026 | Watts Ryan J. | President and CEO | Sell | 35,198 | $16.50 | $580.8K | 0 |
| Aug 12, 2025 | Ho Carole | Chief Medical Officer | Sell | 806 | $14.64 | $11.8K | 0 |
| Aug 12, 2025 | Schuth Alexander O. | COFO and Secretary | Sell | 2,937 | $13.58 | $39.9K | 0 |
| Jul 9, 2025 | Watts Ryan J. | President and CEO | Sell | 495,282 | $15.00 | $7.43M | 0 |
| Jan 8, 2025 | Krognes Steve E. | Director | Sell | 3,339 | $20.81 | $69.5K | 25,757 |
| Jan 8, 2025 | Ho Carole | Chief Medical Officer | Sell | 15,162 | $20.33 | $308.3K | 178,580 |
| Jan 8, 2025 | Schuth Alexander O. | COFO and Secretary | Sell | 15,162 | $20.33 | $308.3K | 247,215 |
| Jan 8, 2025 | Watts Ryan J. | President and CEO | Sell | 36,916 | $20.34 | $751.0K | 260,721 |
| Jan 3, 2025 | Krognes Steve E. | Director | Sell | 30,000 | $20.25 | $607.5K | 29,096-51% |
| Jan 3, 2025 | SATO VICKI L | Director | Sell | 3,080 | $20.91 | $64.4K | 107,976 |
| Nov 13, 2024 | Schenkein David P | Director | Sell | 59,441 | $32.51 | $1.93M | 41,532-59% |
| Nov 12, 2024 | SATO VICKI L | Director | Sell | 1,020 | $30.00 | $30.6K | 111,056 |
| Nov 12, 2024 | Schuth Alexander O. | COFO and Secretary | Sell | 15,558 | $29.91 | $465.3K | 181,291 |
| Nov 5, 2024 | SATO VICKI L | Director | Sell | 3,080 | $27.07 | $83.4K | 112,076 |
| Oct 22, 2024 | Watts Ryan J. | President and CEO | Sell | 40,000 | $27.69 | $1.11M | 235,807 |
| Oct 2, 2024 | Krognes Steve E. | Director | Sell | 30,000 | $29.03 | $870.9K | 29,096-51% |
| Sep 16, 2024 | SATO VICKI L | Director | Sell | 1,020 | $30.00 | $30.6K | 115,156 |
| Sep 4, 2024 | SATO VICKI L | Director | Sell | 3,080 | $25.00 | $77.0K | 116,276 |
| Aug 22, 2024 | Ho Carole | Chief Medical Officer | Sell | 22,458 | $24.49 | $549.9K | 138,815 |
| Aug 22, 2024 | Krognes Steve E. | Director | Sell | 1,727 | $23.79 | $41.1K | 32,677 |
| Aug 22, 2024 | Schuth Alexander O. | COFO and Secretary | Sell | 8,353 | $23.99 | $200.4K | 183,966 |
| Aug 22, 2024 | Watts Ryan J. | President and CEO | Sell | 2,260 | $23.79 | $53.8K | 235,807 |
| Aug 15, 2024 | Ho Carole | Chief Medical Officer | Sell | 2,337 | $22.89 | $53.5K | 141,268 |
| Aug 15, 2024 | Schuth Alexander O. | COFO and Secretary | Sell | 2,272 | $22.89 | $52.0K | 186,419 |
| Jul 3, 2024 | Krognes Steve E. | Director | Sell | 30,688 | $22.11 | $678.7K | 52,620-37% |
| Jul 3, 2024 | SATO VICKI L | Director | Sell | 3,080 | $22.14 | $68.2K | 119,356 |
| Jun 10, 2024 | Cook Jennifer E. | Director | Sell | 1,458 | $21.73 | $31.7K | 20,038 |
| May 17, 2024 | SATO VICKI L | Director | Sell | 1,674 | $20.39 | $34.1K | 116,369 |
| Apr 17, 2024 | SATO VICKI L | Director | Sell | 1,666 | $18.29 | $30.5K | 118,043 |
| Apr 2, 2024 | Krognes Steve E. | Director | Sell | 92,500 | $20.50 | $1.90M | 47,341-66% |
| Mar 19, 2024 | SATO VICKI L | Director | Sell | 1,666 | $20.10 | $33.5K | 119,709 |
| Feb 20, 2024 | SATO VICKI L | Director | Sell | 1,666 | $18.37 | $30.6K | 121,375 |
| Feb 15, 2024 | Ho Carole | Chief Medical Officer | Sell | 4,189 | $17.46 | $73.1K | 145,010 |
| Feb 15, 2024 | Krognes Steve E. | Director | Sell | 2,750 | $17.29 | $47.5K | 139,841 |
| Feb 15, 2024 | Schuth Alexander O. | COFO and Secretary | Sell | 22,844 | $17.62 | $402.4K | 207,469 |
| Feb 15, 2024 | Watts Ryan J. | President and CEO | Sell | 9,589 | $17.29 | $165.8K | 238,067 |
| Jan 18, 2024 | SATO VICKI L | Director | Sell | 1,666 | $18.42 | $30.7K | 123,041 |
| Jan 12, 2024 | Ho Carole | Chief Medical Officer | Sell | 4,668 | $19.02 | $88.8K | 147,794 |
| Jan 11, 2024 | Watts Ryan J. | President and CEO | Sell | 7,818 | $19.78 | $154.6K | 2,268,363 |
| Jan 9, 2024 | Ho Carole | Chief Medical Officer | Sell | 9,972 | $19.43 | $193.8K | 198,777 |
| Jan 9, 2024 | Krognes Steve E. | Director | Sell | 3,208 | $19.43 | $62.3K | 142,591 |
| Jan 9, 2024 | Schuth Alexander O. | COFO and Secretary | Sell | 9,972 | $19.43 | $193.8K | 539,307 |
| Jan 9, 2024 | Watts Ryan J. | President and CEO | Sell | 17,483 | $19.43 | $339.7K | 2,276,181 |
| Dec 18, 2023 | SATO VICKI L | Director | Sell | 1,666 | $23.39 | $39.0K | 124,707 |
| Nov 16, 2023 | SATO VICKI L | Director | Sell | 1,666 | $19.13 | $31.9K | 126,373 |
Showing 1–50 of 157
1 / 4
DNLI Insider Buying Activity
The following table shows recent insider purchases of Denali Therapeutics Inc. (DNLI) stock reported via SEC Form 4 filings.
No insider buying activity found for DNLI in the last 12 months.
DNLI Insider Selling Activity
The following table shows recent insider sales of Denali Therapeutics Inc. (DNLI) stock reported via SEC Form 4 filings.
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| Sep 9, 2026 | Chin Peter Scott | officer: Chief Medical Officer | Sell | 1,654 | $22.29 | $36.9K | 204,538 |
| Sep 4, 2026 | Thornberry Nancy | director | Sell | 11,439 | $22.90 | $261.9K | 20,301-36% |
| Sep 3, 2026 | Schuth Alexander O. | officer: COFO and Secretary | Sell | 2,768 | $23.44 | $64.9K | 278,995 |
| Aug 13, 2026 | Schuth Alexander O. | officer: COFO and Secretary | Sell | 2,857 | $25.07 | $71.6K | 281,763 |
| Jan 6, 2026 | Schuth Alexander O. | COFO and Secretary | Sell | 17,218 | $16.50 | $284.1K | 0 |
| Jan 6, 2026 | Watts Ryan J. | President and CEO | Sell | 35,198 | $16.50 | $580.8K | 0 |
| Aug 12, 2025 | Ho Carole | Chief Medical Officer | Sell | 806 | $14.64 | $11.8K | 0 |
| Aug 12, 2025 | Schuth Alexander O. | COFO and Secretary | Sell | 2,937 | $13.58 | $39.9K | 0 |
| Jul 9, 2025 | Watts Ryan J. | President and CEO | Sell | 495,282 | $15.00 | $7.43M | 0 |
| Jan 8, 2025 | Krognes Steve E. | Director | Sell | 3,339 | $20.81 | $69.5K | 25,757 |
| Jan 8, 2025 | Ho Carole | Chief Medical Officer | Sell | 15,162 | $20.33 | $308.3K | 178,580 |
| Jan 8, 2025 | Schuth Alexander O. | COFO and Secretary | Sell | 15,162 | $20.33 | $308.3K | 247,215 |
| Jan 8, 2025 | Watts Ryan J. | President and CEO | Sell | 36,916 | $20.34 | $751.0K | 260,721 |
| Jan 3, 2025 | Krognes Steve E. | Director | Sell | 30,000 | $20.25 | $607.5K | 29,096-51% |
| Jan 3, 2025 | SATO VICKI L | Director | Sell | 3,080 | $20.91 | $64.4K | 107,976 |
| Nov 13, 2024 | Schenkein David P | Director | Sell | 59,441 | $32.51 | $1.93M | 41,532-59% |
| Nov 12, 2024 | SATO VICKI L | Director | Sell | 1,020 | $30.00 | $30.6K | 111,056 |
| Nov 12, 2024 | Schuth Alexander O. | COFO and Secretary | Sell | 15,558 | $29.91 | $465.3K | 181,291 |
| Nov 5, 2024 | SATO VICKI L | Director | Sell | 3,080 | $27.07 | $83.4K | 112,076 |
| Oct 22, 2024 | Watts Ryan J. | President and CEO | Sell | 40,000 | $27.69 | $1.11M | 235,807 |
| Oct 2, 2024 | Krognes Steve E. | Director | Sell | 30,000 | $29.03 | $870.9K | 29,096-51% |
| Sep 16, 2024 | SATO VICKI L | Director | Sell | 1,020 | $30.00 | $30.6K | 115,156 |
| Sep 4, 2024 | SATO VICKI L | Director | Sell | 3,080 | $25.00 | $77.0K | 116,276 |
| Aug 22, 2024 | Ho Carole | Chief Medical Officer | Sell | 22,458 | $24.49 | $549.9K | 138,815 |
| Aug 22, 2024 | Krognes Steve E. | Director | Sell | 1,727 | $23.79 | $41.1K | 32,677 |
| Aug 22, 2024 | Schuth Alexander O. | COFO and Secretary | Sell | 8,353 | $23.99 | $200.4K | 183,966 |
| Aug 22, 2024 | Watts Ryan J. | President and CEO | Sell | 2,260 | $23.79 | $53.8K | 235,807 |
| Aug 15, 2024 | Ho Carole | Chief Medical Officer | Sell | 2,337 | $22.89 | $53.5K | 141,268 |
| Aug 15, 2024 | Schuth Alexander O. | COFO and Secretary | Sell | 2,272 | $22.89 | $52.0K | 186,419 |
| Jul 3, 2024 | Krognes Steve E. | Director | Sell | 30,688 | $22.11 | $678.7K | 52,620-37% |
| Jul 3, 2024 | SATO VICKI L | Director | Sell | 3,080 | $22.14 | $68.2K | 119,356 |
| Jun 10, 2024 | Cook Jennifer E. | Director | Sell | 1,458 | $21.73 | $31.7K | 20,038 |
| May 17, 2024 | SATO VICKI L | Director | Sell | 1,674 | $20.39 | $34.1K | 116,369 |
| Apr 17, 2024 | SATO VICKI L | Director | Sell | 1,666 | $18.29 | $30.5K | 118,043 |
| Apr 2, 2024 | Krognes Steve E. | Director | Sell | 92,500 | $20.50 | $1.90M | 47,341-66% |
| Mar 19, 2024 | SATO VICKI L | Director | Sell | 1,666 | $20.10 | $33.5K | 119,709 |
| Feb 20, 2024 | SATO VICKI L | Director | Sell | 1,666 | $18.37 | $30.6K | 121,375 |
| Feb 15, 2024 | Ho Carole | Chief Medical Officer | Sell | 4,189 | $17.46 | $73.1K | 145,010 |
| Feb 15, 2024 | Krognes Steve E. | Director | Sell | 2,750 | $17.29 | $47.5K | 139,841 |
| Feb 15, 2024 | Schuth Alexander O. | COFO and Secretary | Sell | 22,844 | $17.62 | $402.4K | 207,469 |
| Feb 15, 2024 | Watts Ryan J. | President and CEO | Sell | 9,589 | $17.29 | $165.8K | 238,067 |
| Jan 18, 2024 | SATO VICKI L | Director | Sell | 1,666 | $18.42 | $30.7K | 123,041 |
| Jan 12, 2024 | Ho Carole | Chief Medical Officer | Sell | 4,668 | $19.02 | $88.8K | 147,794 |
| Jan 11, 2024 | Watts Ryan J. | President and CEO | Sell | 7,818 | $19.78 | $154.6K | 2,268,363 |
| Jan 9, 2024 | Ho Carole | Chief Medical Officer | Sell | 9,972 | $19.43 | $193.8K | 198,777 |
| Jan 9, 2024 | Krognes Steve E. | Director | Sell | 3,208 | $19.43 | $62.3K | 142,591 |
| Jan 9, 2024 | Schuth Alexander O. | COFO and Secretary | Sell | 9,972 | $19.43 | $193.8K | 539,307 |
| Jan 9, 2024 | Watts Ryan J. | President and CEO | Sell | 17,483 | $19.43 | $339.7K | 2,276,181 |
| Dec 18, 2023 | SATO VICKI L | Director | Sell | 1,666 | $23.39 | $39.0K | 124,707 |
| Nov 16, 2023 | SATO VICKI L | Director | Sell | 1,666 | $19.13 | $31.9K | 126,373 |
DNLI Insiders
Similar Stocks to DNLI
VRTX
Vertex Pharmaceuticals Incorporated
$513.52-1.17%
$132.26B
REGN
Regeneron Pharmaceuticals, Inc.
$772.87-2.63%
$83.21B
MRNA
Moderna, Inc.
$142.93-2.49%
$57.13B
RVMD
Revolution Medicines, Inc.
$204.47-0.31%
$44.15B
INSM
Insmed Incorporated
$119.56-4.63%
$28.05B
INCY
Incyte Corporation
$121.65-0.43%
$24.62B
UTHR
United Therapeutics Corporation
$500.44-0.42%
$21.10B
NBIX
Neurocrine Biosciences, Inc.
$150.44-4.31%
$15.71B